Digital Quality Management Systems as Strategic Enablers of Patient-Centric Manufacturing Excellence
Rise of AI ML-Powered Accelerators in Pharma Secure Supply Chain
AI in Pharmaceutical Manufacturing Operations
Single Use Technologies (SUT) in Pharmaceutical Manufacturing
Redefining RNA Manufacturing Through Innovation in Biocatalysis
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Building the Bridge: How B2B Media Is Shaping the Future of Chemical Engineering
The shift is already well underway BB medias value used to be measured in reach how many engineers received your magazine how many clicks your digital...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
How to Build a Compliant Pharma Email Strategy Using Automation Tools
Email is not a marketing channel in pharma Its a controlled communication environment Every message sentto a healthcare professional a distributor or even an internal stakeholdersits within a framework of regulations Unlike retail or SaaS marketing you dont get the luxury of experimentation without oversight There are rules Documentation Approvals And repercussions in case one of them slips
-
Techno Trends
FORE Biotherapeutics Receives FDA Breakthrough Therapy Designation for Plixorafenib in Brain Cancer
FORE Biotherapeutics has received Breakthrough Therapy Designation from the US Food and Drug Administration FDA for its investigational drug plixorafenib developed for the treatment of adult patients with BRAF VEmutated highgrade glioma a severe form of brain cancer
-
Projects
Cambrex Announces $150 Million Expansion across U.S. and European Facilities
Cambrex has revealed significant progress on its expansion initiatives across the United States and Europe These projects are designed to boost capacity for manufacturing complex drugs
-
Research Insights
Gene expression and metadata based identification of key genes for lung cancer, COPD, and IPF using machine learning and statistical models
Lung cancer LC is one of the most prevalent and deadly cancers globally presenting a major public health challenge Patients with chronic obstructive pulmonary disease COPD and idiopathic pulmonary fibrosis
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Pharma Supply Chain Digitalization: 7 Strategies to Boost Transparency and Efficiency in 2026
Kate Williamson
The future of the Pharma supply chain is digitalizing the industry in a way that it is reshaping operational resilience, transparency and efficiency in the year 2026. This article discusses seven stra...
-
2
Challenges and Opportunities in Cell and Gene Therapy Manufacturing
Kate Williamson
The widespread use of cell and gene therapy manufacturing gets restricted by three main factors which include high production costs and regulatory complexities along with limited scalability. Modern a...
-
3
Understanding the Complexities of Drug Approval in the U.S. Pharma Landscape
Debi Jones
The stages of approval of the drugs in the United States involve the new drugs in check by the FDA to determine whether they are fit for consumption in humans as they are effective in tackling various...
-
4
Revolutionizing Drug Design for a Brighter Future: Harnessing the Power of Artificial Intelligence and Machine Learning
Vidya Niranjan
In this editorial, we explore the remarkable potential of artificial intelligence (AI) and machine learning (ML) in revolutionizing the field of drug design. Traditional drug discovery pipelines have...
-
5
Biosimilars in the U.S.: Unraveling Market Dynamics and Winning B2B Collaboration Strategies
Kate Williamson
This B2B guide delves into the dynamic landscape of biosimilars in the U.S., offering insights into market dynamics and successful collaboration strategies. From understanding regulatory challenges to...
press releasesRead more...
AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus
AbbVie today announced a billion investment to build a acre pharmaceutical manufacturing campus in Durham North Carolina The stateoftheart campus will integrate advanced manufacturing
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
Polaryx Therapeutics Inc Nasdaq PLYX a clinicalstage biotechnology company developing diseasemodifying therapies for rare pediatric LSDs today announced that the US Food and Drug Administration
Entos Pharmaceuticals and the L-CMD Research Foundation Collaborate to Develop Curative Therapy for LMNA-Related Congenital Muscular Dystrophy
Entos Pharmaceuticals Inc Entos a clinicalstage company that develops genetic medicines utilizing its nonviral redosable Fusogenix PLV delivery platform is proud to announce a collaboration
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
Eli Lilly and Company NYSE LLY and Kelonia Therapeutics Inc Kelonia a clinicalstage biotechnology company pioneering in vivo gene delivery today announced a definitive agreement for Lilly to acquire Kelonia
Events Read more...
29 - 30
Apr 2026Pharma Partnering US Summit 2026
Hilton San Diego, USA
05 - 06
May 2026GENAP Summit 2026
Vienna, Austria
06 - 07
May 20262nd Edition MaxPotent Pharma Summit 2026
Milan, Italy
06 - 07
May 202641th pharmacovigilance USA 2026
Boston, USA
07 - 08
May 202621st PPM for Pharma & Biotech
New Jersey, USA
10 - 14
May 2026Respiratory Drug Delivery 2026
The Westin Kierland Phoenix, Arizona, USA
20 - 21
May 2026Pharmacovigilance Europe 2026
London, UK
20 - 22
May 2026PHARMA EURASIA 2026
Pharma & Med Tech Park, Tashkent, Uzbekistan
LATEST NEWSRead more...
Helus Pharma Names Jill Conwell Chief People Officer
Helus Pharma a clinicalstage company advancing novel serotonergic agonists appoints experienced HR leader Jill Conwell as Chief People Officer to bolster talent strategy amid key pipeline milestones
OrganaBio and RxMP Therapeutics Partner to Support Manufacturing of RMP-402
OrganaBio and RxMP Therapeutics have announced a manufacturing partnership to advance the development of RMP a novel haemostatic drug candidate designed to control severe bleeding
AbbVie $1.4B NC Manufacturing Expansion
AbbVie is investing billion to establish a new production base in North Carolina enhancing its biopharmaceutical manufacturing capabilities amid growing demand for innovative therapies
BioAegis and Prenosis Collaborate to Advance AI-Driven Precision Medicine in Inflammatory Diseases
BioAegis Therapeutics a clinicalstage biotechnology company focused on inflammatory diseases has entered into a strategic collaboration with Prenosis a specialist in artificial intelligencedriven precision medicine
FDA Accepts Roche Application for Gazyva/Gazyvaro in Systemic Lupus Erythematosus
Roche has received acceptance from the US Food and Drug Administration FDA for its supplemental Biologics License Application sBLA for GazyvaGazyvaro obinutuzumab to treat systemic lupus erythematosus
Helus Pharma Names Jill Conwell CPO
Helus Pharma a clinicalstage firm advancing novel serotonergic agonists appoints experienced executive Jill Conwell as Chief People Officer effective immediately
